|
|
Article: United Research Laboratories/Mutual Pharmaceutical Company Announce ANDA Filing for Guaifenesin Extended-Release Tablets, 600 mg and 1200 mg.
- Article from:
- PR Newswire
- Article date:
- August 18, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PHILADELPHIA, Aug. 18 /PRNewswire/ -- United Research Laboratories and Mutual Pharmaceutical Company today announce that Mutual has filed an Abbreviated New Drug Application (ANDA) with the Food and Drug Administration (FDA), seeking approval to market Mutual's guaifenesin extended-release tablets, 600 mg and 1200 mg. Guaifenesin extended-release tablets are currently marketed over-the-counter by Adams Respiratory Therapeutics under the brand name Mucinex(R). According to Adams, Mucinex(R) is one of the most widely recommended OTC products to treat chest congestion and related coughs.
On August 9, 2006, FDA determined that Mutual's guaifenesin extended-release ...